Trial Profile
Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2020
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms VIH-IBAN
- 12 Mar 2019 Status changed from suspended to withdrawn prior to enrolment.
- 23 Jan 2010 New trial record